BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 1310852)

  • 1. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
    Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
    Teng CM; Hsueh CM; Chang YL; Ko FN; Lee SS; Liu KC
    J Pharm Pharmacol; 1997 Jul; 49(7):706-11. PubMed ID: 9255715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet actions of some coumarin compounds isolated from plant sources.
    Teng CM; Li HL; Wu TS; Huang SC; Huang TF
    Thromb Res; 1992 Jun; 66(5):549-57. PubMed ID: 1523611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effects of protopine isolated from Corydalis tubers.
    Ko FN; Wu TS; Lu ST; Wu YC; Huang TF; Teng CM
    Thromb Res; 1989 Oct; 56(2):289-98. PubMed ID: 2559491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans.
    Ko FN; Chen IS; Wu SJ; Lee LG; Haung TF; Teng CM
    Biochim Biophys Acta; 1990 May; 1052(3):360-5. PubMed ID: 2162213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
    Liao CH; Ko FN; Wu CL; Teng CM
    J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet effect of demethyldiisoeugenol.
    Liao CH; Ko FN; Kuo YH; Teng CM
    Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation.
    Ko FN; Yeh LJ; Liang HC; Kuo SC; Teng CM
    J Pharm Pharmacol; 1996 Apr; 48(4):395-400. PubMed ID: 8794990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets.
    Liao CH; Ko FN; Kuo SC; Teng CM
    Jpn J Pharmacol; 1998 Feb; 76(2):141-8. PubMed ID: 9541276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina.
    Tsai WJ; Hsieh HT; Chen CC; Kuo YC; Chen CF
    Eur J Pharmacol; 1998 Apr; 346(1):103-10. PubMed ID: 9617759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
    Chou TC; Hsu LY; Yen MH; Ding YA
    Thromb Res; 1996 Oct; 84(2):83-95. PubMed ID: 8897698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thrombin- and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist--denudatin B, an isomer of kadsurenone.
    Teng CM; Yu SM; Chen CC; Huang YL; Huang TF
    Thromb Res; 1990 Jul; 59(1):121-30. PubMed ID: 2169076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
    Matsuoka I; Nakahata N; Nakanishi H
    Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory mechanisms of dantrolene on platelet aggregation.
    Chou TC; Li CY
    Thromb Res; 1999 Nov; 96(4):299-307. PubMed ID: 10593433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.